Can you get weight loss injections on the NHS?

The myth worth clearing up first: 'anyone can get these on the NHS'

Social media posts and news headlines have given many people the impression that weight loss injections are now freely available through GPs. That's not quite right. Tirzepatide and semaglutide have both been recommended by NICE and are making their way onto the NHS, but the rollout is staged deliberately, and the entry bar at each stage is high. A question our prescribers hear most weeks is some version of 'my BMI is 32 and I have high blood pressure — why can't I get it on the NHS?' The short answer is that the current cohort requires a BMI of at least 35, four qualifying conditions, and access through a service that may not yet exist in your area.

NICE's appraisal of tirzepatide, TA1026, sets out the phased eligibility in detail. It's useful reading if you want to understand what the NHS is actually commissioning, rather than what headlines suggest.

Where the NHS stands on weight loss injections right now

The NHS rollout for tirzepatide is structured around four cohorts. The first opened in June 2025: adults in England with a BMI of 40 or above plus four or more of five specific conditions, high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. The second cohort activated on 23 June 2026, bringing in adults with a BMI of 35–39.9 who also carry four of those same conditions. Further cohorts are expected from around March 2027 onwards.

For some ethnic backgrounds (including South Asian, Chinese, Middle Eastern, Black African and African-Caribbean backgrounds) BMI thresholds are set 2.5 kg/m² lower under UK guidance, which can make a real difference in practice. Even so, every NHS patient must engage with wrap-around diet and activity support; meeting the BMI and condition criteria doesn't guarantee access, particularly if your GP practice hasn't yet joined the new prescribing pathway or your area's specialist service has a waiting list. Full eligibility detail for NHS weight loss injections is worth reviewing before assuming you qualify or don't.

Wegovy (semaglutide) sits in a slightly different position: it's recommended by NICE under TA875 but only within specialist weight management services, for a maximum of two years, and with multidisciplinary support. Waiting lists for those services are commonly long across England.

If you don't meet the NHS criteria, what are your options?

Private treatment through a regulated online pharmacy is the main alternative. Both Mounjaro and Wegovy are licensed in the UK for private prescription at lower BMI thresholds than the current NHS cohorts require, broadly, a BMI of 30 or above, or 27 and above with at least one weight-related condition. If you're wondering whether a pharmacist can prescribe weight loss injections, the answer depends on their independent prescriber registration, and a GPhC-registered prescriber assesses your full medical picture before any prescription is issued. Strictly speaking, eligibility isn't just a number; it's a clinical judgement.

The cost side of private treatment is worth understanding clearly. There's a practical guide to the real cost of weight loss injections that covers what legitimate private prices typically include and what to watch for when a price looks surprisingly low. For an overview of the full range of licensed options, the weight loss treatment overview covers both injection and tablet routes currently available in the UK.

On safety, the same standards apply whether treatment is NHS or private. These are prescription-only medicines, dispensed through a pharmacy you can verify on the GPhC register. If you want confidence you're using the best company to buy weight loss injections from, checking that they operate with a verifiable GPhC registration is a reliable starting point, because any seller offering them without a prescription is operating outside the law.

How to get weight loss injections on the NHS if you think you qualify

Start with your GP. If your BMI and conditions put you in the current NHS cohort, your GP may be able to prescribe under the updated GP contract (in place from April 2026), or refer you to a specialist weight management service. Availability varies by practice and integrated care board, so persistence matters. Ask specifically about tirzepatide prescribing and whether your practice is participating in the new pathway. The NHS England guidance on weight management injections sets out what to expect from the wrap-around support your GP should put in place alongside any prescription.

If you sit just outside the current NHS thresholds and prefer not to wait, a private consultation is a straightforward way to find out whether you're eligible for treatment now. At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber, meet our clinical team to understand what that oversight looks like in practice. To explore the private route in full, including what the NHS process looks like step by step, our treatment pages are a good place to start.